Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Global Embryo Culture Media Market to Grow at a CAGR of 9.2% by 2021 - Growing Number of Delayed Pregnancies & Increase in Awareness of IVF Treatment - Research and Markets
By: PR Newswire Association LLC. - 29 May 2017Back to overview list

DUBLIN, May 29, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Embryo Culture Media Market 2017-2021" report to their offering.

The global embryo culture market to grow at a CAGR of 9.28% during the period 2017-2021.

The report, Global Embryo Culture Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, there is a notable increase in the awareness of ART procedures among women when compared with the last decade. ART procedures such as IVF treatment have gained a positive perception and wide acceptance among women worldwide. The increase in awareness can be attributed to several factors such as the rise in education level among the female population, coupled with the rise in the number of working women. This has had a significant influence on the demand for various IVF treatments, especially in developed and developing countries such as the US, the UK, and China.

Further, the report states that infertility treatments such as IVF treatment are considered a lifestyle procedures rather than serious medicine. Health insurance plans generally pay for services related to testing for infertility. For instance, in the US, which does not have any infertility coverage mandate, most insurance policies do not support fertility and IVF service payment. Some insurance providers cover testing and treatment up to and including intrauterine insemination but excluding IVF. In addition, while the monitoring of IVF ovarian stimulation (blood and ultrasound tests) is often covered, IVF codes are not covered.

Key vendors

  • Cook Medical
  • CooperSurgical
  • Irvine Scientific
  • Vitrolife

Other prominent vendors

  • EMD Serono
  • ESCO Micro
  • Genea
  • IVFtech
  • NMC Healthcare
  • The Baker Company
  • Thermo Fisher Scientific

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Fertility tourism

PART 07: Geographical segmentation

PART 08: Segmentation by end-user

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Key vendor analysis

PART 15: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/5xcnmd/global_embryo

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related companies:Ascendiant Capital | Wombat Capital | Research On Global Markets
Copyright 2017 PR Newswire Association LLC. Back to overview list
to the top ↑